Two seven-gene phenazine biosynthetic loci were cloned from Pseudomonas aeruginosa PAO1. The operons, designated phzA1B1C1D1E1F1G1 and phzA2B2C2D2E2F2G2, are homologous to previously studied phenazine biosynthetic operons from Pseudomonas fluorescens and Pseudomonas aureofaciens. Functional studies of phenazine-nonproducing strains of fluorescent pseudomonads indicated that each of the biosynthetic operons from P. aeruginosa is sufficient for production of a single compound, phenazine-1-carboxylic acid (PCA). Subsequent conversion of PCA to pyocyanin is mediated in P. aeruginosa by two novel phenazine-modifying genes, phzM and phzS, which encode putative phenazine-specific methyltransferase and flavin-containing monooxygenase, respectively. Expression of phzS alone in Escherichia coli or in enzymes, pyocyanin-nonproducing P. fluorescens resulted in conversion of PCA to 1-hydroxyphenazine. P. aeruginosa with insertionally inactivated phzM or phzS developed pyocyanin-deficient phenotypes. A third phenazine-modifying gene, phzH, which has a homologue in Pseudomonas chlororaphis, also was identified and was shown to control synthesis of phenazine-1-carboxamide from PCA in P. aeruginosa PAO1. Our results suggest that there is a complex pyocyanin biosynthetic pathway in P. aeruginosa consisting of two core loci responsible for synthesis of PCA and three additional genes encoding unique enzymes involved in the conversion of PCA to pyocyanin, 1-hydroxyphenazine, and phenazine-1-carboxamide.
Phenazine compounds produced by fluorescent Pseudomonas species are biologically active metabolites that function in microbial competitiveness (37) , the suppression of soilborne plant pathogens (1, 11, 55, 56) , and virulence in human and animal hosts (35) .
The most widely studied phenazine-producing fluorescent pseudomonad is P. aeruginosa, a gram-negative opportunistic pathogen of animals, insects, nematodes, and plants (30, 33, 35, 46) . In humans, P. aeruginosa infects immunocompromised, burned, or injured patients and can cause both acute and chronic lung disease. Strains of P. aeruginosa produce a variety of redox-active phenazine compounds, including pyocyanin, phenazine-1-carboxylic acid (PCA), 1-hydroxyphenazine (1-OH-PHZ), and phenazine-1-carboxamide (PCN) (7, 52, 57) .
From 90 to 95% of P. aeruginosa isolates produce pyocyanin (52) , and the presence of high concentrations of pyocyanin in the sputum of cystic fibrosis patients has suggested that this compound plays a role in pulmonary tissue damage observed with chronic lung infections (64) . This idea is supported by several recent studies which demonstrated that pyocyanin contributes in a variety of ways to the pathophysiological effects observed in airways infected by P. aeruginosa. Pyocyanin interferes with the regulation of ion transport, ciliary beat frequency, and mucus secretion in airway epithelial cells by altering the cytosolic concentration of calcium (15) . It may interact with endothelium-derived relaxing factor or with nitric oxide (which plays a central role in the control of blood pressure, blood flow, and immune function) through the formation of a complex, or it may act by inhibition of nitric oxide synthase (29, 58, 59) . Phenazines that are produced by P. aeruginosa also can stimulate alveolar macrophages to produce two neutrophil chemotaxins, IL-8 and leukotriene B 4 , that attract neutrophils into airways, causing an inflammatory response and neutrophil-mediated tissue damage (14, 33) .
The unusually broad range of biological activity associated with phenazines is thought to be due to their ability to undergo redox cycling in the presence of various reducing agents and molecular oxygen, which leads to the accumulation of toxic superoxide (O 2 Ϫ ) and hydrogen peroxide (H 2 O 2 ) and eventually to oxidative cell injury or death (6, 25) . It also has been shown that pyocyanin can interact synergistically with the siderophore pyochelin and with transferrin cleaved by proteases secreted by both P. aeruginosa and neutrophils in infected lungs to catalyze the formation of the highly cytotoxic hydroxyl radical (·OH), which damages pulmonary endothelial cells (6, 38) . In model pathogenesis systems, phenazine synthesis by P. aeruginosa is required for the generation of disease symptoms in plants and for effective killing of the nematode Caenorhabditis elegans and the greater wax moth, Galleria mellonella (30, 35, 46) . Phenazine compounds produced in the rhizosphere of plants contribute to the biological control activity of P. aeruginosa against Fusarium wilt of chickpea and Pythium dampingoff of bean (1) .
Although the pathophysiological effects of phenazines produced by P. aeruginosa in host organisms are well studied (6, 14, 15, 33, 34, 38, 64) and pyocyanin-deficient phenotypes frequently have been described (18, 19, 26, 32, 35, 46, 54) , the biochemistry and genetics of phenazine synthesis in P. aeruginosa have remained unclear. We describe here cloning and functional analysis of two seven-gene phenazine operons and three phenazine-modifying genes from P. aeruginosa PAO1. Our results show that P. aeruginosa contains a complex phenazine biosynthetic pathway consisting of two homologous core loci (phzA1B1C1D1E1F1G1 and phzA2B2C2D2E2F2G2) responsible for synthesis of PCA and three additional genes (phzM, phzS, and phzH) encoding unique enzymes involved in the conversion of PCA to pyocyanin and PCN. We detected the core biosynthetic operon by Southern hybridization in 21 phenazine-producing pseudomonads, including strains of P. aeruginosa, Pseudomonas fluorescens, Pseudomonas chlororaphis, and Pseudomonas aureofaciens, but not in seven phenazine-producing isolates of Burkholderia cepacia, Burkholderia phenazinium, and Brevibacterium iodinum. Thus, the core biosynthetic pathway is highly conserved in fluorescent Pseudomonas spp. but differs significantly from that in other phenazine-producing bacterial genera.
MATERIALS AND METHODS
Bacterial strains and plasmids. All of the bacterial strains and plasmids used in this study are described in Table 1 . Strains of P. fluorescens, P. aeruginosa, P. chlororaphis, P. aureofaciens, B. cepacia, B. phenazinium, and B. iodinum were grown at 28°C in Luria-Bertani (LB) broth (2) . Escherichia coli strains were grown at 28 or 37°C in LB medium. To examine phenazine production, P. aeruginosa strains were grown on PIA plates (Difco Laboratories, Detroit, Mich.) or in PB medium (containing [per liter of distilled water] 20 g of Bacto Peptone [Difco Laboratories], 1.4 g of MgCl 2 , and 10 g of K 2 SO 4 ) (18) for 1 to 3 days at 28 or 37°C. Strains of P. fluorescens were tested for phenazine production in LB medium supplemented with 2% glucose. The antibiotics used in this study were gentamicin (300 g/ml) and carbenicillin (500 g/ml) in experiments with mutant derivatives of P. aeruginosa; tetracycline (15 to 20 and 100 g/ml) in experiments with isolates of P. fluorescens and P. aeruginosa, respectively; and ampicillin (80 g/ml) and tetracycline (12.5 g/ml) in experiments with E. coli. DNA manipulations. Standard methods were used for plasmid DNA isolation, restriction enzyme digestion, agarose gel electrophoresis, ligation, and transformation (2) . Pseudomonad cells were electroporated with a Gene Pulser system (Bio-Rad Laboratories, Hercules, Calif.) by using the procedure of Enderle and Farwell (17) . Total DNA from P. aeruginosa was isolated and purified by using a cetyltrimethylammonium bromide miniprep procedure (2) .
A 6.4-kb DNA probe containing the entire phz locus from P. fluorescens 2-79 (GenBank accession number L48616) was generated by PCR performed with oligonucleotide primers PHZ-UP and PHZ-LOW (Table 1 ). The amplification was carried out by using a 50-l reaction mixture containing 1ϫ eLONGase buffer (Life Technologies, Inc., Rockville, Md.), 2 mM MgSO 4 , 3.0% dimethyl sulfoxide (Sigma Chemical Co., St. Louis, Mo.), 200 M (each) dGTP, dATP, dTTP, and dCTP (Perkin-Elmer, Norwalk, Conn.), 10 pmol of each primer, 0.7 l of eLONGase enzyme mixture (Life Technologies, Inc.), and 20 ng of purified genomic DNA from strain 2-79. All amplifications were performed with a PTC-200 thermal cycler (MJ Research, Inc., Watertown, Mass.). The cycling program included a 30-s initial denaturation step at 94°C, followed by 30 cycles of 94°C for 30 s, 64°C for 30 s, and 72°C for 7 min. The PCR product was gel purified and labeled with a random primer biotin labeling kit (NEN Life Science Products Inc., Boston, Mass.). Other PCR amplifications were carried out by using 25-l reaction mixtures that contained 1ϫ Taq DNA polymerase buffer (Life Technologies, Inc.), 1.5 mM MgCl 2 , 200 M (each) dGTP, dATP, dTTP, and dCTP, 20 pmol of each primer, 1.2 U of Platinum Taq DNA polymerase (Life Technologies, Inc.), and 20 ng of target DNA.
DNA samples used for Southern hybridization were digested with restriction endonucleases, separated by electrophoresis in 0.8% agarose gels, and transferred to BrightStar-Plus nylon membranes (Ambion, Inc., Austin, Tex.) in 0.4 M NaOH, and there was subsequent cross-linking of the DNA by exposure of the membranes to UV radiation (2) . Hybridization analyses were carried out as described previously (13) . DNA-DNA hybrids were detected with a BrightStar nonisotopic detection kit (Ambion, Inc.) by using the manufacturer's protocol.
Insertional inactivation of phzM and phzS genes. P. aeruginosa PAO1 phzM and phzS knockout mutants were generated by using a gene replacement strategy previously described by Schweizer (50) . To mutagenize phzM, the gene was amplified by PCR with oligonucleotide primers METHYL1 and METHYL2 (Table 1 ) from cosmid 1G5 DNA of P. aeruginosa. The 1.26-kb PCR product was digested with EcoRI and BamHI, cloned into pNOT19, and inactivated by insertion of an 879-bp aacC1 cassette from pUCGM into a unique EcoRV site (Fig. 1A) . The resulting plasmid, pNOT-ORF1-Gm, was digested with NotI and ligated with the 5.3-kb MOB3 sacB cassette (50) .
To inactivate phzS, the gene was amplified from cosmid 1G5 target DNA with oligonucleotide primers OXY1 and OXY2 (Table 1 ). The 1.24-kb PCR product was digested with XbaI and SphI, gel purified, and cloned into pNOT-19. The aacC1 cassette was then inserted into a unique ScaI site within phzS (Fig. 1A) . The resulting plasmid, pNOT-ORF2-Gm, was ligated to the MOB3 sacB cassette and used for mutagenesis.
Plasmids containing the sacB cassette and the inactivated phzM or phzS gene were mobilized in P. aeruginosa PAO1 from E. coli S17-1. Following selection for double crossovers, isolates were screened by PCR for the presence of plasmidborne bla and sacB genes in the genome. The ␤-lactamase gene was detected by PCR performed with primers BLA1 and BLA2 ( DNA sequencing and analysis. DNA was sequenced by using an ABI PRISM dye terminator cycle sequencing kit (Perkin-Elmer, Norwalk, Conn.). All oligonucleotides were obtained from Operon Technologies, Inc. (Alameda, Calif.). Sequence data were compiled and analyzed with the Genetics Computer Group package (22) and the OMIGA 2.0 software package (Oxford Molecular Ltd., Oxford, United Kingdom). A database search for similar protein sequences was carried out with OMIGA's BLAST tool. A probable domain similarity search was performed by using the PROSITE (European Molecular Biology Laboratory, Heidelberg, Germany) (3) and ISREC ProfileScan (Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland) (4) web servers. The significance of the similarity of a predicted protein to known proteins was determined by calculating the binary comparison score (Z score) as described elsewhere (13) . Similarities with Z scores grater than 9 were considered significant.
Multiple sequence alignments were constructed with OMIGA's ClustalW. Phylogenetic analyses were carried out with PHYLIP 3.57c software (20) . Distance matrices were generated with PROTDIST. Trees were inferred from the distances by using NEIGHBOR and FITCH with global rearrangement. Protein parsimony analyses were carried out with the PROTPARS program of the PHYLIP package. PHYLIP's SEQBOOT program was used for bootstrap analyses.
The present study was greatly facilitated by the use of the P. aeruginosa genome web site resources (http://www.pseudomonas.com).
Phenazine transformation assays. Cultures of E. coli JM109 bearing pUCP26, pUCP-M, pUCP-S, pUCP-H, or pUCP-phnAB (Table 1) were grown in 2ϫ YT (2) supplemented with tetracycline and were induced with 0.5 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) at an optical density at 600 nm of 0.6. Immediately after induction, PCA was added to a final concentration of 0.3 mg/ml from a 25 mM stock solution in 5% (wt/vol) NaHCO 3, and the cultures were grown for 6 h. Samples were extracted with chloroform at 3-h intervals and analyzed for phenazine composition by reverse-phase high-performance liquid chromatography (HPLC).
Cross-feeding experiments. Overnight cultures of E. coli JM109 bearing pUCP26-based plasmids were diluted 1:100 in fresh 2ϫ YT broth supplemented with tetracycline, grown with shaking to an optical density at 600 nm of 0.6, and induced with 0.5 mM IPTG. Immediately after induction, PCA was added to a concentration of 0.3 mg/ml, and the cultures were grown for 6 h to allow phenazine metabolites to accumulate. Finally, E. coli cells were removed by centrifugation and passage through a 0.22-m-pore-size filter, and the filtrates were added to broth cultures of E. coli JM109 bearing pUCP26, pUCP-S, or pUCP-M. After 6 h of bacterial growth, phenazines were extracted with chloroform and analyzed by reverse-phase HPLC and mass spectrometry.
Analyses of phenazine compounds. Phenazine compounds were extracted from bacterial cultures with chloroform, filtered (pore size, 0.2 m), and sub- TAAGGATCCGGTAGTTCCAAGCCCCAGAAAC  PHZ-LOW  CACATTTGATCTAGATGGGTCACGGCTATTCAG  METHYL1  TTTTTGAATTCTTTCGGACGCAGGAAAAG  METHYL2  TTTTTGGATCCGTTGAAAGTTCCGATTCA  OXY1  TCGAACACTCTAGAAAAGGAAGCACC  OXY2  TTTTTTGCATGCTAGCGTGGCCGTTCC  phzHup  CGCACGGATCCTTTCAGAATGTTC  phzHlow  GCCACGCCAAGCTTCACGCTCA  BLA1  GGCCCCAGTGCTGCAATGATAC  BLA2  GAGTATTCAACATTTCCGTGTCGC  SAC1  GATGTTTTCTTGCCTTTGATGTTC  SAC2 GTCTTTGCATTAGCCGGAGATC a Phz ϩ , strain produces phenazines; Phz Ϫ , strain does not produce phenazines; Phz(?) strains was not tested for phenazine production; iodinin, 1,6-dihydroxyphenazine 5,10-di-N-oxide; 2-OH-PCA, 2-hydroxyphenazine-1-carboxylic acid; 2-OH-PHZ, 2-hydroxyphenazine; aeruginosin A, 5-methyl-7-amino-1-carboxyphenazinium betaine; aeruginosin B, 5-methyl-7-amino-1-carboxy-3-sulfophenazinium betaine; bla, ␤-lactamase; Rif r , rifampin resistance; Tet r , tetracycline resistance. b ATCC, American Type Culture Collection.
jected to C 18 reverse-phase HPLC. Analyses were performed by using a Waters HPLC Integrity system consisting of an Alliance 2690 separation module, a 996 photodiode array detector, and an electron ionization ThermaBeam mass detector. Phenazine compounds were separated on a Symmetry C 18 column (5 m; 3.0 by 150 mm). The solvent flow rate was 350 l min Ϫ1 , and the flow consisted of 2 min of 8% acetonitrile-25 mM ammonium acetate, followed by a 25-min linear gradient to 80% acetonitrile-25 mM ammonium acetate. A filtered 1 M ammonium acetate solution was used to prepare all solvents. HPLC gradient profiles were monitored at spectral peak maxima of 257.0 and 313.0 nm, which are characteristic of PCA and pyocyanin in the solvent system used. Mass spectrometry total-intensity chromatogram analyses were performed from m/z 100 to 355 at a rate of 1 scan s Ϫ1 . The nebulizer, ion source, and expansion region temperatures were 84, 220, and 80°C, respectively, with a helium flow rate of 15 lb/in 2 . The UV spectra and mass spectral characteristics of the major phenazine compounds detected are summarized in Fig. 2A .
Reference samples of pyocyanin and PCA were purchased from Colour Your Enzyme (Bath, Ontario, Canada). Mass spectrometry analyses of protonated (molecular weight, 211) and unprotonated (molecular weight, 210) forms of synthetic pyocyanin revealed the presence of an unknown m/z 224 ion peak [m/z (relative intensity) 224 (13) 211(58) (10) 75 (5)] that was not detected (Fig. 2) when the same reference samples were analyzed with a Voyager matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer (PerSeptive Biosystems, Framingham, Mass.), in which no heating of the sample occurred. The predominant peak detected was at m/z 211, which corresponded to the protonated form of pyocyanin. The MALDI-TOF analyses were carried out in dihydrobenzoic and ␣-cyano-4-hydroxycinnamic acids with an acceleration voltage of 2,500 V (positive ion), a grid voltage of 60%, a guide wire voltage of 0.03%, and a delay of 150. We concluded that the m/z 224 peak was the product of a thermally promoted intermolecular reaction in the ThermoBeam mass spectral detector, which is consistent with the observations of Watson et al. (60) . Phenazine compounds extracted from P. chlororaphis ATCC 17809 and ATCC 17411 were used as a source of reference material for PCN because the synthetic compound was not available. Both of these strains are well characterized and are known to produce large amounts of PCN (52) . The retention time, UV spectra, and mass spectral characteristics of the major phenazine compounds produced by each of these strains were identical to those of the other and to those of the putative PCN peak observed in extracts from P. aeruginosa or E. coli expressing phzH from PAO1 in the presence of PCA (data not shown).
Nucleotide sequence accession numbers. The GenBank accession numbers for the nucleotide sequence data for the phzA1B1C1D1E1F1G1 and phzA2B2C2D2 E2F2G2 operons from P. aeruginosa PAO1 are AF005404 and AE004616, respectively. 
RESULTS
Detection, cloning, and sequence analysis of phzA1B1C1D1E 1F1G1 and phzA2B2C2D2E2F2G2. The phzA1B1C1D1E1F1G1 genes were initially detected in P. aeruginosa PAO1 by Southern hybridization of total DNA restriction digests with a probe containing the phzCD genes from P. fluorescens 2-79. The analysis identified a 2.4-kb PstI-EcoRI DNA fragment that hybridized strongly to the 2-79 phzCD probe (data not shown). The fragment was cloned into pUC19, and two positive clones, plasmids p137 and p143, were identified by colony hybridization with the phenazine-specific probe (Fig. 1) . Sequence analysis indicated that the cloned DNA fragment contained a complete sequence similar to phzD and partial flanking sequences similar to phzC and phzE of 2-79. The DNA from plasmid p143 was then used as a probe to screen a P. aeruginosa PAO1 genomic library (a membrane with arrayed cosmid DNA was a kind gift from Stephen Lory). Four positive cosmid clones were identified, and clone 1G5 was chosen for further study. After restriction mapping, a 10-kb BglII-NotI DNA fragment containing the phenazine biosynthetic genes was subcloned into pUCP26, and the resulting plasmid, pUCP-1G5, was used to determine the complete nucleotide sequence of the phenazine biosynthetic locus phzA1B1C1D1E1F1G1 from P. aeruginosa PAO1 (Fig. 1A) .
The complete DNA sequence of the operon (GenBank accession number AF005404) is identical to the corresponding region of the P. aeruginosa PAO1 genome that was described by Stover et al. (53) . Computer analyses of the DNA sequence of clone 1G5 revealed seven open reading frames, designated phzA1 through phzG1, located in the P. aeruginosa PAO1 genome at positions 4,713,795 to 4,720,062 (Fig. 1A) . A wellconserved ribosome binding site precedes each gene. The stop and start codons of open reading frames phzC1, phzD1, and phzE1 overlap, possibly reflecting translational coupling. A 16-bp region of imperfect dyad symmetry (5Ј-CTACCAGAT CTTGTAG-3Ј) located 372 bp upstream of phzA1 is similar to putative lux boxes found upstream of the phzA gene in P. fluorescens 2-79 and P. aureofaciens 30-84 (36, 43) , suggesting that expression of the gene cluster is regulated in a cell densitydependent manner. Sequence comparisons indicated that phzA1B1C1D1E1F1G1 from P. aeruginosa is structurally and functionally homologous to the phenazine biosynthetic loci of P. fluorescens 2-79 (36), P. aureofaciens 30-84 (43) , and P. chlororaphis PCL1391 (10) (data not shown).
Similarity searches performed with the PAO1 genome revealed a second copy of the phenazine cluster containing seven genes, designated phzA2B2C2D2E2F2G2 (Fig. 1B) 
Identification of phzM, phzS, and phzH genes in the P. aeruginosa PAO1 genome database. We identified two potential phenazine-modifying genes in P. aeruginosa PAO1 by analysis of the genomic region containing phzA1B1C1D1E1F1G1. This operon is flanked by genes designated PA4209 and PA4217 in the PAO1 database (53) . PA4209, referred to in this paper as phzM, is preceded by a putative ribosome binding site, GAGAGA, and spans positions 4,713,098 to 4,712,094 in the PAO1 genome. The phzA1B1C1D1E1F1G1 operon and phzM are transcribed divergently and are separated by 695 bp (Fig.  1A) . phzM encodes a 334-residue protein with a calculated molecular mass of 36. PA4217, referred to in this paper as phzS, is located 236 bp downstream from phzG1 and spans positions 4,720,300 to 4,721,508 of the P. aeruginosa PAO1 genome. phzS is preceded by a well-conserved ribosome binding site, AAGGAA, and encodes a 402-amino-acid protein with a molecular mass of 43.6 kDa. PhzS is similar to bacterial monooxygenases, including salicylate hydroxylase (NahW) from Pseudomonas stutzeri (NCBI accession number AAD02157; 27.7% identity; Z score, 38.9), a putative salicylate hydroxylase (SCE29.14c) from S. coelicolor (accession number T36193; 37.5% identity; Z score, FIG. 2. UV and mass spectra of PCA, pyocyanin (PYO), PCN, and 1-OH-PHZ produced by P. aeruginosa PAO1 (A). (B) HPLC analyses of phenazine compounds produced by wild-type P. aeruginosa PAO1; P. fluorescens 2-79 harboring pUCP26; P. fluorescens 2-79 harboring pUCP-MS; E. coli JM109 harboring pUCP-A1G1, containing phzA1B1C1D1E1F1G1; a mixture of E. coli JM109 harboring pUCP-A1G1 and E. coli JM109 harboring pUCP-MS; E. coli JM109 harboring pUCP-A2G2, containing phzA2B2C2D2E2F2G2; and a mixture of E. coli JM109 harboring pUCP-A2G2 and E. coli JM109 harboring pUCP-MS. The identities of phenazine compound peaks were confirmed by spectral analysis and mass spectrometry. The retention times for PCA, pyocyanin, PCN, and 1-OH-PHZ with the solvent system used in this study were 9.4, 10.6, 16.4, and 18.2 min, respectively. The absorption maxima for PCA were at 251 and 364 nm; the absorption maxima for pyocyanin were at 237, 313, and 376 nm; the absorption maxima for PCN were at 246 and 364 nm; and the absorption maxima for 1-OH-PHZ were at 259 and 367 nm. AU, absorbance units. A third potential phenazine-modifying gene was identified in the P. aeruginosa genome by using the sequence of the recently described phzH gene from P. chlororaphis PCL1391 (10) as a query sequence in a BLAST search (10) . This search identified the PA0051 gene, which exhibits 80.3% identity to phzH and spans positions 66,303 to 68,135 in the P. aeruginosa genome (53) . This gene, referred to in this paper as phzH, is preceded by a well-conserved ribosome binding site, GAGG, and encodes a 610-amino-acid protein with a calculated molecular mass of 69.5 kDa. The deduced amino acid sequence encoded by phzH most closely resembles the sequence of phenazinemodifying enzyme PhzH from P. chlororaphis (NCBI accession number AAF17502; 80.3% identity; Z score, 556.5) and is similar to the sequences of bacterial asparagine synthetases, including TcsG from Streptomyces aureofaciens (accession number BAB12569; 46.1% identity; Z score, 267.9), PA2084 from P. aeruginosa (accession number AAG05472; 45.4% identity; Z score, 291.6), and AsnO from Bacillus subtilis (accession number O05272; 40.2% identity; Z score, 273.3). Two wellconserved Pfam protein motifs commonly associated with asparagine synthetases were found in PhzH: the glutamine amidotransferase class II signature (residues 43 to 153) and an asparagine synthetase signature (residues 199 to 608).
Functional analyses of the core phenazine loci and the phnAB genes from P. aeruginosa PAO1. To determine the function of the phenazine genes from P. aeruginosa, each of the seven-gene operons was cloned in pUCP26 under control of the lac promoter. The resulting plasmids, pUCP-A1G1 and pUCP-A2G2 (Fig. 1) , and pUCP-1G5 were expressed in P. fluorescens M4-80, which does not produce phenazines, and in P. fluorescens 2-79, which produces a single phenazine compound, PCA. Extracts from each plasmid-bearing strain were analyzed by HPLC and mass spectrometry, and the data were compared to elution profiles and spectra generated with synthetic pyocyanin or extracts from wild-type P. fluorescens 2-79 and P. aeruginosa PAO1. Extracts from P. aeruginosa PAO1 contained a mixture of pyocyanin, 1-OH-PHZ, and PCA. Only PCA was detected in extracts from strain M4-80 containing either pUCP-A1G1 or pUCP-A2G2 (Table 2) . Similar results were obtained for derivatives of strain 2-79, in which the presence of either plasmid led to increased levels of PCA accumulation (data not shown) but did not change the range of compounds synthesized (Table 2 ). In contrast, strain 2-79 bearing pUCP-1G5 produced large amounts of both PCA and the derivative 1-OH-PHZ (Table 2) . Plasmid pUCP-1G5 contained the complete phzA1B1C1D1E1F1G1 operon and 3.3 kb of additional downstream DNA.
Previous studies of tryptophan biosynthesis in P. aeruginosa identified the phnAB genes (18) , which encode an anthranilate synthase homologue that complements trpE and trpE(G) mutants of E. coli. PhnAB also contributes to pyocyanin synthesis in P. aeruginosa, and pyocyanin production by phnA mutants is greatly reduced (18) . To further evaluate the role of phnAB in pyocyanin synthesis, the genes were excised from M13-10116 phage (the phage DNA was a kind gift from M. G. Bangera) by digestion with SacI and KpnI, treated with T4 DNA polymerase, and inserted into the SmaI site of pUCP26. The resulting plasmid, pUCP-phnAB, was introduced into P. fluorescens M4-80R and 2-79 by electroporation, and transformants were assayed for phenazine production by HPLC. In no case was pyocyanin produced, and strain 2-79 produced only PCA (Table 2) in quantities comparable to those detected in 2-79 containing pUCP26.
We also conducted phenazine transformation assays to determine whether phnAB conferred the ability to transform PCA, a precursor of pyocyanin and 1-OH-PHZ, into other phenazine compounds. This approach has proven to be useful in characterizing other genes encoding phenazine-modifying enzymes (13) . Cultures of E. coli JM109 containing pUCPphnAB or the control plasmid pUCP26 were induced with IPTG and incubated for 9 h in the presence of 0.3 mg of PCA ml Ϫ1 . HPLC analyses revealed that the extracts from E. coli JM109(pUCP-phnAB) were identical to those from the control strain, and no conversion of PCA to pyocyanin or any other phenazine derivative was detected (data not shown).
Functional analyses of phzM, phzS, and phzH. To determine whether phzM, phzS, and phzH encode phenazine-modifying enzymes, gene function was analyzed in E. coli transformed with pUCP-M, pUCP-S, pUCP-H, and pUCP-MS (Table 1) . These plasmids were constructed by amplifying phzM, phzS, and phzH from PAO1 genomic DNA with oligonucleotide primers METHYL1 and METHYL2, oligonucleotide primers OXY1 and OXY2, and oligonucleotide primers phzHup and phzHlow, respectively ( Table 1 ). The PCR products were digested with restriction endonucleases, gel purified, and cloned into pUCP26 under control of the lac promoter (Fig. 1) . To construct pUCP-MS, pUCP-M was digested with XbaI and SphI, and the PCR fragment containing phzS was cloned immediately downstream of phzM. All plasmids were single-pass sequenced to confirm the integrity of cloned gene(s).
Induced cultures of E. coli bearing pUCP-MS converted PCA to pyocyanin within 6 h, whereas no such conversion occurred in control cultures harboring only pUCP26 (data not shown). We did not detect derivatives of PCA in supernatants of E. coli JM109(pUCP-M) cultures incubated under similar conditions, although these cultures were an intense dark red. Induced cultures of E. coli JM109 bearing pUCP-S and E. coli bearing pUCP-H converted PCA to 1-OH-PHZ and PCN, respectively (data not shown). We were able to restore the complete pyocyanin biosynthetic pathway in E. coli by mixing induced cultures containing either pUCP-A1G1 or pUCP-A2G2 with a culture containing pUCP-MS. HPLC analysis revealed that in both cases the mixed cultures produced small but detectable amounts of pyocyanin (Fig. 2B) . Plasmid pUCP-MS also was introduced into P. fluorescens 2-79. Overnight broth cultures of 2-79(pUCP-MS) were intensely blue, which was consistent with synthesis of pyocyanin, and the results of HPLC and mass spectrometry analyses (Fig.  2B) confirmed that large amounts of this compound were present.
Effect of phzM and phzS mutations on pyocyanin production. The gene replacement approach was used to evaluate the role of the phenazine-modifying genes phzM and phzS in pyocyanin biosynthesis in P. aeruginosa PAO1. Mutant derivatives with mutations in phzM (strain PAOmxM) or phzS (strain PAOmxS) exhibited unusual pigment phenotypes when they were cultivated on PIA. Whereas cultures of wild-type PAO1 were blue due to production of pyocyanin, cultures of P. aeruginosa PAOmxM were yellow, and P. aeruginosa PAOmxS produced large amounts of a dark red water-soluble pigment (Fig. 3) . Chloroform extracts prepared from cultures of these mutants grown in PB medium were analyzed by HPLC and mass spectrometry (Table 2) . Both mutants were able to synthesize PCA and PCN but did not produce pyocyanin. In fact, the phzM mutant produced and secreted more PCN than the parent strain (data not shown). PAOmxM produced 1-OH-PHZ, although it produced markedly less than the parental strain, while no 1-OH-PHZ was detected in extracts from PAOmxS. Finally, complementation of PAOmxM and PAOmxS with pUCP-M and pUCP-S, respectively, restored production of pyocyanin (Table 2) .
DISCUSSION
The present study demonstrated clearly that the opportunistic human pathogen P. aeruginosa PAO1 contains two complete copies of a seven-gene operon shown previously (13, 36, 43) to be responsible for the synthesis of PCA. We also screened a collection of 30 bacterial strains, including isolates of P. aeruginosa, P. fluorescens, P. chlororaphis, P. aureofaciens, Pseudomonas putida, B. cepacia, B. phenazinium, and B. iodinum (Table 1) , for the presence of these core phenazine biosynthetic genes by performing Southern hybridization with probes spanning phzA through phzG. Similar sequences were not detected in phenazine-producing isolates of B. cepacia, B. phenazinium, and B. iodinum under moderately stringent conditions (6ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 55°C) despite the fact that the same mechanism of phenazine synthesis is thought to function in all of these genera (34, 52, 57) . Only total DNA from 26 known phenazine-producing strains of P. aeruginosa, P. aureofaciens, P. chlororaphis, and P. fluorescens hybridized strongly to the phenazine gene probe (data not shown), indicating not only that the operon is conserved in phenazine-producing fluorescent pseudomonads but also that it may be unique to them.
Of the pseudomonads, only P. aeruginosa has been found to contain two copies of the phenazine operon. Both copies are homologous to phenazine biosynthetic loci from P. aureofaciens, P. fluorescens, and P. chlororaphis (13, 36, 43) , and both are functional, as each enabled the non-phenazine-producing strain P. fluorescens M4-80R to synthesize PCA, which was implicated previously as a pyocyanin precursor (8) . Although the two phenazine operons of P. aeruginosa PAO1 are 98% identical overall, they differ markedly in their promoter regions. In fluorescent Pseudomonas species, phenazine production occurs mainly during the stationary phase and is regulated by quorum sensing and the highly conserved, global, two-component signal transduction system, GacA-GacS (44, 47) . The N-acyl-homoserine lactone-mediated regulation of phenazine (63) recently identified the phzA1B1C1D1E1F1G1 operon among the genes controlled by quorum sensing in P. aeruginosa. This operon is preceded by a well-conserved putative promoter element required for quorum control, the las box (Fig. 1) . Interestingly, no such element is present upstream of phzA2B2C2D2E2F2G2.
On the other hand, analyses of the PAO1 genome have revealed a gene, qscR, that is similar to lasR and rhlR and is located upstream of phzA2B2C2D2E2F2G2 (Fig. 1) . According to Chugani et al. (12) , qscR encodes a protein that negatively regulates expression of a number of quorum-sensingcontrolled genes via repression of lasI and lasI-regulated target genes, including phzA1B1C1D1E1F1G1. It is tempting to speculate that the presence of two differentially regulated phenazine biosynthetic operons may give the bacterium greater flexibility in modulating the amount or range of phenazine compounds produced depending on the phase of growth or in response to environmental signals.
Recently, Mahajan-Miklos et al. (35) demonstrated that phenazines are involved in the killing of C. elegans by the clinical isolate P. aeruginosa PA14. The pathogenicities of two pyocyanin-deficient mutants of P. aeruginosa PA14, both containing a TnphoA insertion in a gene similar to phzB1, were reduced in the Caenorhabditis killing model, in Arabidopsis leaf infiltration assays, and in the burned mouse model. Interestingly, inactivation of phzB reduced pyocyanin production in strain PA14 but did not eliminate it entirely (35) . These results are consistent with expression of a second, differently regulated copy of the phz genes in the PA14 genome. We compared the proteins encoded by phzA and phzB from P. aeruginosa PA14 with the corresponding products of the P. aeruginosa PAO1 genes. The results of cluster analyses (data not shown) indicated that the products of the phzA and phzB genes of strain PA14 most closely resemble PhzA2 and PhzB2 from P. aeruginosa PAO1 (all bootstrap values were Ն81%). These data suggest that PAO1 is not unique in containing two homologous phz operons, and the trait may be common among strains of P. aeruginosa. It remains to be determined whether this unusual feature is typical of both environmental and clinical isolates and if it is relevant to the role in pathogenesis of pyocyanin and other phenazines produced by P. aeruginosa.
Our results indicate that specific genes in P. aeruginosa are required for conversion of PCA to pyocyanin and PCN. At least two modifications would be expected in the conversion of PCA to pyocyanin: addition of the N-methyl group, converting PCA to 5-methylphenazine-1-carboxylate betaine; and hydroxylative decarboxylation of the betaine to form pyocyanin (8, 52, 57) . Using DNA sequence information from the Pseudomonas Genome Project (www.pseudomonas.com), we identified two potential genes in the vicinity of the phzA1B1C 1D1E1F1G1 operon (Fig. 1) that could encode the required PCA-modifying enzymes. Several lines of evidence support the idea that phzM and phzS play essential roles in the pyocyanin biosynthetic pathway. Transformation of the PCA-producing strain P. fluorescens 2-79 with phzM and phzS triggered synthesis of large amounts of pyocyanin (Table 2) . We also were able to reconstitute the full pathway for biosynthesis of pyocyanin in E. coli by mixing induced cultures expressing phzMS with cultures expressing phzA1B1C1D1E1F1G1 or phzA2B2C2D2E2F 2G2 (Fig. 2B) . Finally, E. coli expressing phzM and phzS efficiently converted exogenously supplied PCA to pyocyanin. These data are consistent with results of mutagenesis studies in which P. aeruginosa marker exchange mutants with mutations in phzM and phzS failed to produce detectable amounts of pyocyanin (Table 2) .
Our results support the results of previous studies (8, 21, 51 ) that predicted the existence of a phenazine methyltransferase and a phenazine-specific hydroxylase in the pyocyanin biosynthetic pathway. Byng et al. (8) attempted to determine the exact relationship among the different phenazine compounds synthesized by P. aeruginosa. Their study yielded three different groups of mutant strains: one group that produced no phenazines; a second group that synthesized PCA and PCN; and a third group that produced PCA, PCN, and the dark red compounds aeruginosins A and B (8, 9) . The members of the second group of mutants identified by Byng et al. appear to be phenotypically identical to the phzM knockout strain, while the members of the third group resemble the phzS knockout strain ( Table 2 ). Our data raise questions concerning the identity of the dark red compound characterized previously as a complex of aeruginosin A (5-methyl-7-amino-1-carboxymethylphenazinium betaine) and aeruginosin B (5-methyl-7-amino-1-carboxy-3-sulfophenazinium betaine) and thought to be derived from PCA via a specific biosynthetic pathway (8) . We were surprised to find that E. coli expressing phzM alone converted PCA to a dark red compound(s) similar in appearance to the product(s) synthesized by phzS mutants of P. aeruginosa (Fig.  3) . Unfortunately, we were unable to identify this material by C 18 reverse-phase HPLC because the pigment is extremely hydrophilic and could not be extracted with the solvents commonly used to recover phenazines. These properties are similar to those of the aeruginosins described previously by Herbert and Holliman (27) and Holliman (28) . We hypothesize that the dark red pigment synthesized by P. aeruginosa PAOmxS mutants and by E. coli expressing phzM is not a complex of aeruginosins A and B but rather is a colored intermediate (probably 5-methylphenazine-1-carboxylic acid betaine) formed through methylation of PCA by PhzM.
PhzM is a predicted 36.4-kDa protein similar to enzymes involved in the methylation of polyketide antibiotics by Streptomyces spp. Streptomycetes produce a variety of bioactive polyketides, many of which contain methyl groups introduced via the action of N-and O-methyltransferases (16, 66) . PhzM most closely resembles O-methyltransferases from Streptomyces spp. and shares with them a putative catalytic domain (residues 137 to 177) that might be universal among SAMdependent methyltransferases (4) . The presence of a potential SAM binding site in the N-terminal part of PhzM (residues 67 to 176) further supports the idea that PhzM functions as a methyltransferase.
The second putative phenazine-modifying gene, phzS, is located immediately downstream of phzA1B1C1D1E1F1G1 (Fig.  1) and encodes a predicted 43.6-kDa protein similar to putative salicylate hydroxylases from S. coelicolor (GenBank accession numbers T36193 and CAB95795), Bordetella pertussis (AAC46266), Acinetobacter sp. strain ADP1 (AAC27110), and P. aeruginosa (AAG06716) and NahW from P. stutzeri AN10 (AAD02157). NahW is of particular interest as it is the best-characterized enzyme related to PhzS. According to Bosch et al. (5), nahW encodes a flavoprotein monooxygenase with broad substrate specificity that catalyzes conversion of salicylic acid and its derivatives to catechol. In a detailed sequence analysis of NahW, they identified several conserved motifs present in bacterial salicylate hydroxylases. A sequence comparison of PhzS with NahW and other salicylate hydroxylases revealed that PhzS contains the consensus NADH binding domain (159-DVLVGADGIHSAVR-172), putative N-terminal flavin adenine dinucleotide binding site , and substrate active site (303-GRITLLGDAAHLMYPM GANGA-323). Not only is PhzS clearly involved in the biosynthesis of pyocyanin, but it is also probably responsible for the production of 1-OH-PHZ by P. aeruginosa. E. coli expressing phzS efficiently converted exogenously supplied PCA to 1-OH-PHZ, and we also detected 1-OH-PHZ in extracts from the P. aeruginosa phzM mutant (Table 2) . Thus, our results suggest that 1-OH-PHZ is formed from PCA via enzymatic synthesis and not through light-mediated decomposition of pyocyanin, as proposed previously (45) . In fact, no traces of decomposition were found in solutions of synthetic pyocyanin after 5 days of incubation at room temperature under direct light (data not shown).
We suggest that two steps are involved in the synthesis of pyocyanin from PCA (Fig. 4) . In the first step, catalyzed by the SAM-dependent methyltransferase PhzM, PCA is converted to 5-methylphenazine-1-carboxylic acid betaine. The second step, catalyzed by the NADH (or NADPH)-dependent flavoprotein monooxygenase PhzS, involves hydroxylative decarboxylation of 5-methylphenazine-1-carboxylic acid betaine to pyocyanin. In cross-feeding studies to determine the order of the two reactions, we detected pyocyanin only when cultures of E. coli expressing phzS were incubated with filtered extracts from cultures expressing phzM (data not shown). When cultures expressing phzM were incubated for 6 h with filtered extracts from cultures expressing phzS, only PCA and 1-OH-PHZ were detected. We speculate that the ability of PhzS to convert PCA to 1-OH-PHZ can be explained by the broad substrate specificity of the enzyme.
The gene for biosynthesis of PCN was identified in the P. aeruginosa database by using the recently discovered phzH gene from P. chlororaphis (10) as the query sequence. E. coli expressing phzH converted exogenously supplied PCA to PCN (data not shown), confirming that phzH from P. aeruginosa is functionally homologous to its counterpart from P. chlororaphis. The deduced product of these genes is similar to class II glutamine amidotransferases, namely, to asparagine synthases. The closest functionally characterized enzyme with similarity to PhzH is the asparagine synthetase AsnO from B. subtilis. Bacterial asparagine synthetases are grouped into two families (68); the first comprises enzymes similar to E. coli AsnA that accept only ammonia as the amino donor, whereas the members of the second family resemble E. coli AsnB and can use both ammonia and glutamine as amino donors (48) . According to Yoshida et al. (68) , asnO encodes an AsnB type of asparagine synthase crucial for sporulation in B. subtilis. Based on the sequence similarity and function data, we propose that phzH of P. aeruginosa encodes a glutamine-dependent, phenazine-specific amidotransferase that catalyzes the amidation of PCA to PCN (Fig. 4) .
A question then arises concerning the role of the phnAB genes, which have been implicated previously in pyocyanin production. These genes initially were characterized by Essar et al. (18) and were found to encode products resembling the anthranilate synthase subunits TrpE and TrpG. However, unlike trpE and trpG, which encode a typical tryptophan-specific anthranilate synthase in P. aeruginosa, phnA and phnB are cotranscribed and expressed during the stationary phase (18). Essar et al. also demonstrated that phnAB could complement trpE and trpE(G) mutants of E. coli and that PhnAB was not feedback inhibited by tryptophan. Insertional inactivation of phnA significantly reduced pyocyanin synthesis, an observation confirmed later by other workers (1, 35, 46) ; however, production was not eliminated completely, and mutants synthesized pyocyanin at levels that were 22 to 34% of the wild-type levels, which was attributed to the activity of TrpEG (18) . Essar et al. suggested that PhnAB functions as a phenazine-specific an-thranilate synthase, providing anthranilic acid as a precursor for pyocyanin production.
To further evaluate the role of these genes, we expressed phnAB in P. fluorescens 2-79, which produces only PCA, and in M4-80R, which does not produce phenazine. The introduced genes neither enhanced nor enabled PCA production in these strains (Table 2) , nor did E. coli JM109 expressing phnAB convert PCA to other phenazines. Recent studies of the mechanism of phenazine nucleus assembly indicate that PCA is synthesized via the conversion, catalyzed by PhzE and PhzD, of 2-amino-2-deoxyisochorismic acid to 2,3-dihydroxy-3-hydroxyanthranilate (M. G. McDonald, D. V. Mavrodi, L. S. Thomashow, and H. G. Floss, unpublished data). Thus, anthranilic acid is not a precursor in the formation of the phenazine nucleus. Therefore, it seems likely that PhzE1 and PhzE2 in P. aeruginosa are largely responsible for the conversion of chorismic acid to PCA via the same mechanism proposed (36) for PhzE in P. fluorescens 2-79. There is ample evidence that PhnA and PhnB influence pyocyanin production in P. aeruginosa (1, 18, 35, 46) , but it seems unlikely that they participate directly in assembly of the phenazine nucleus. The precise role of these enzymes in P. aeruginosa metabolism, the identities of intermediates, and the products involved remain to be discovered. These uncertainties reinforce the fact that despite numerous biochemical studies of pyocyanin biosynthesis, the actual enzymology and genetic control are still not well understood and require further investigation.
